If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> REPRODUCTIVE<br /> HEALTH<br /> EMJ Repro Health. 2019 Suppl 3 • europeanmedical-journal.com<br /> INSIDE<br /> Assisted Reproductive<br /> Technologies Across<br /> a Heterogeneous<br /> Patient Population<br /> Assisted Reproductive Technologies Across a<br /> Heterogeneous Patient Population<br /> This symposium took place on Tuesday 25th June 2019 as part<br /> of the European Society of Human Reproduction and Embryology<br /> (ESHRE) annual meeting in Vienna, Austria.<br /> Chairpeople: Marco Filicori (Italy),1 Joop Laven (The Netherlands)2<br /> Speakers: Valerie Baker (USA),3 Nick Raine-Fenning (UK),4,5 Pauline Wijngaard-<br /> Boom (The Netherlands)6<br /> 1. Reproductive Medicine Unit, GynePro Medical Group, Bologna, Italy<br /> 2. Division of Reproductive Medicine, Department of Obstetrics and Gynecology,<br /> Erasmus MC, Rotterdam, The Nether<a title="EMJ Repro Health 2019 Suppl 3 page 1" href="http://viewer.zmags.com/publication/ed6d9faa?page=1"> REPRODUCTIVE HEALTH EMJ Repro Health. 2019 Suppl</a> <a title="EMJ Repro Health 2019 Suppl 3 page 2" href="http://viewer.zmags.com/publication/ed6d9faa?page=2"> Assisted Reproductive Technologies Across a </a> <a title="EMJ Repro Health 2019 Suppl 3 page 3" href="http://viewer.zmags.com/publication/ed6d9faa?page=3"> highly purified human menopausal gonadotrophin (HP</a> <a title="EMJ Repro Health 2019 Suppl 3 page 4" href="http://viewer.zmags.com/publication/ed6d9faa?page=4"> Unexplained Uterine infertility </a> <a title="EMJ Repro Health 2019 Suppl 3 page 5" href="http://viewer.zmags.com/publication/ed6d9faa?page=5"> models can be applied to observational data and c</a> <a title="EMJ Repro Health 2019 Suppl 3 page 6" href="http://viewer.zmags.com/publication/ed6d9faa?page=6"> HP-hMG rFSH Ongoing pregnancy rate (%) 30 27 </a> <a title="EMJ Repro Health 2019 Suppl 3 page 7" href="http://viewer.zmags.com/publication/ed6d9faa?page=7"> Due to the distinct properties of follitropin del</a> <a title="EMJ Repro Health 2019 Suppl 3 page 8" href="http://viewer.zmags.com/publication/ed6d9faa?page=8"> OS cycles, with advantages observed mainly i</a> <a title="EMJ Repro Health 2019 Suppl 3 page 9" href="http://viewer.zmags.com/publication/ed6d9faa?page=9"> 7. Gershman B et al. Using observational 15</a>